SoftOx Solution AS: New Share Capital

18 Sep 2024 09:59 CEST

Reference is made to the stock exchange release from SoftOx Solutions AS (the
"Company") on 17th of September 2024 regarding the board resolution to increase
the share capital by converting outstanding claims to new shares in the Company.


The new share capital following the completion of the share capital increase has
today been registered with the Norwegian Register of Business Enterprises.

The new share capital of the Company is NOK 39 025 078,84 divided into 1 951 253
942 shares, each with a par value of NOK 0,02.


About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx) is a Medtech and pharmaceutical company listed on
Euronext Growth Oslo under 'SOFTX'. SoftOx Solutions AS was founded in 2012 and
is headquartered in Oslo. The SoftOx Solutions Group includes the holding
company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AB (WIAB),
and subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx
is developing a highly effective antimicrobial solution for use in biofilm,
viral, and antimicrobial-resistant infections. The patent-protected technology
is based on extensive research and development in partnership with leading
Nordic research institutes.


For more information on SoftOx, visit www.soft-ox.com

More information:
Access the news on Oslo Bors NewsWeb site